Potassium Iodide
- Generic Name
- Potassium Iodide
- Brand Names
- Iosat, Pregvit, Thyrosafe, Thyroshield, Xylocaine With Epinephrine
- Drug Type
- Small Molecule
- Chemical Formula
- IK
- CAS Number
- 7681-11-0
- Unique Ingredient Identifier
- 1C4QK22F9J
- Background
Saturated solution of Potassium Iodide (SSKI) is used pharmaceutically for emergency use in patients experiencing acute symptoms of severe hyperthyroidism (also known as thyroid storm or thyrotoxic crisis). SSKI can also be used for radioiodine-contamination emergencies or in preparation of thyrotoxic patients for thyroidectomy.
- Indication
Potassium Iodide is oral antithyroid agent used in the prevention of radioactive iodine uptake into the thyroid gland during a nuclear radiation emergency. Potassium Iodide may be used as an adjunct to other antithyroid agents in the treatment of hyperthyroidism and thyrotoxicosis and preoperatively to induce thyroid involution.
- Associated Conditions
- Acute radiation sickness, Folate deficiency, Goitre, Hypothyroidism, Iodine Deficiency, Iron Deficiency (ID), Thyroid Cancer
- Associated Therapies
- Nutritional supplementation, Skin disinfection, Oral disinfection
Measurement of Iodolipids in the Thyroid Gland and Other Biological Samples
- First Posted Date
- 2022-11-28
- Last Posted Date
- 2022-11-28
- Lead Sponsor
- Prof. Gerasimos Sykiotis
- Target Recruit Count
- 20
- Registration Number
- NCT05628506
Effective Iodide Therapy for Untreated Patients With Graves' Hyperthyroidism Avoiding Thionamide Drugs With Many Side Effects
- First Posted Date
- 2020-12-28
- Last Posted Date
- 2020-12-28
- Lead Sponsor
- Kyushu University
- Target Recruit Count
- 504
- Registration Number
- NCT04686006
131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT03649438
- Locations
- 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
MIBG With Dinutuximab +/- Vorinostat
- Conditions
- Interventions
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2024-11-18
- Target Recruit Count
- 45
- Registration Number
- NCT03332667
- Locations
- 🇺🇸
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta, Georgia, United States
🇺🇸Cook Children's Healthcare System, Fort Worth, Texas, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease
- First Posted Date
- 2009-07-24
- Last Posted Date
- 2015-12-15
- Lead Sponsor
- University of Massachusetts, Worcester
- Target Recruit Count
- 36
- Registration Number
- NCT00946296
- Locations
- 🇺🇸
UMASS Memorial Health Care, Worcester, Massachusetts, United States
Preventing Lack of Iodine During Pregnancy
- First Posted Date
- 2006-09-22
- Last Posted Date
- 2011-10-12
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 374
- Registration Number
- NCT00379535
- Locations
- 🇫🇷
Endocrinology - University Hospital, Toulouse, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.